IRCT201008121778N3已完成未知
Evaluation of Bromocriptin effect on disease activity index in rheumatoid arthritis
Vice chancellor of research, Isfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 100 years（—）
- 性别
- All
入选标准
- •Rheumatoid arthritis patients (proved by ACR criteria) that greater than 16 years old with active R.A (DAS>4) despite conventional thrapy.
- •Exclusion criteria: Drug reaction, lapse from the study, Immigration or death, containdications for bromocriptin
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Investigation of tolerablity & effectiveness of Bromocriptine in comparison with Teneligliptin in patients diagnosed with type II diabetes mellitusCTRI/2018/05/013591asrin Nisha
招募中
2 期
Role of Bromocriptine in patients with difficulty in speech following strokeCTRI/2013/04/003539Dr Reeba Sini Jacob88
招募中
2 期
Role of bromocriptine through enteral route for decreasing neurogenic fever in severe head Injury patients in Trauma Intensive Care Unit.CTRI/2023/08/056344Institute of medical sciences Banaras hindu university
进行中（未招募）
不适用
Überwachung einer Therapie mit Bromocriptin bei Patienten mit klinisch relevanter Risperidon-induzierter Hyperprolaktinämie. Eine psychiatrisch-endokrinologische Ver-laufsbeobachtung.Schizophrene Patienten mit einer Risperidon induzierten HyperprolaktinämieEUCTR2005-006037-33-DEniversitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie
已完成
不适用
Efficacy of bromocriptine on left ventricular function in women with peripartum cardiomyopathy (PPCM)PPCM: Peripartum CardiomyopathyO99.4Diseases of the circulatory system complicating pregnancy, childbirth and the puerperiumDRKS00000407Medizinische Hochschule Hannover, Klinik für Kardiologie und Angiologie63